This study found that inflammatory conditions can change CD133-positive liver stem cells into metastatic stem cells by activating IL-6-mediated inflammatory TAK1-NFκB signaling, which causes hepatocellular carcinoma metastatic development [196]. Here, NFKB1 is linked to hepatocellular carcinoma.